1. Home
  2. HTCR vs CLRB Comparison

HTCR vs CLRB Comparison

Compare HTCR & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • CLRB
  • Stock Information
  • Founded
  • HTCR 2009
  • CLRB 2002
  • Country
  • HTCR Japan
  • CLRB United States
  • Employees
  • HTCR N/A
  • CLRB N/A
  • Industry
  • HTCR EDP Services
  • CLRB Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTCR Technology
  • CLRB Health Care
  • Exchange
  • HTCR Nasdaq
  • CLRB Nasdaq
  • Market Cap
  • HTCR 16.9M
  • CLRB 14.2M
  • IPO Year
  • HTCR 2022
  • CLRB N/A
  • Fundamental
  • Price
  • HTCR $1.07
  • CLRB $5.06
  • Analyst Decision
  • HTCR
  • CLRB Hold
  • Analyst Count
  • HTCR 0
  • CLRB 2
  • Target Price
  • HTCR N/A
  • CLRB N/A
  • AVG Volume (30 Days)
  • HTCR 2.4M
  • CLRB 97.0K
  • Earning Date
  • HTCR 11-13-2025
  • CLRB 11-17-2025
  • Dividend Yield
  • HTCR N/A
  • CLRB N/A
  • EPS Growth
  • HTCR N/A
  • CLRB N/A
  • EPS
  • HTCR N/A
  • CLRB N/A
  • Revenue
  • HTCR $29,625,381.00
  • CLRB N/A
  • Revenue This Year
  • HTCR N/A
  • CLRB N/A
  • Revenue Next Year
  • HTCR $3.52
  • CLRB N/A
  • P/E Ratio
  • HTCR N/A
  • CLRB N/A
  • Revenue Growth
  • HTCR 72.95
  • CLRB N/A
  • 52 Week Low
  • HTCR $0.39
  • CLRB $4.11
  • 52 Week High
  • HTCR $3.38
  • CLRB $67.50
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 58.33
  • CLRB 51.37
  • Support Level
  • HTCR $0.91
  • CLRB $4.82
  • Resistance Level
  • HTCR $1.09
  • CLRB $5.34
  • Average True Range (ATR)
  • HTCR 0.15
  • CLRB 0.34
  • MACD
  • HTCR -0.01
  • CLRB 0.05
  • Stochastic Oscillator
  • HTCR 57.33
  • CLRB 68.85

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Share on Social Networks: